Pacific Edge Limited (PFGTF) has released an update.
Pacific Edge Limited, a New Zealand-based leader in bladder cancer diagnostics, is set to announce its full year financial results on May 21, 2024, with an investor briefing to follow. The company, known for its Cxbladder suite of tests, has a significant clinical track record and is utilized by thousands of US urologists and is widely accessible in New Zealand. Interested parties can join the briefing via webcast or toll-free phone numbers, with the opportunity to ask questions online or during the call.
For further insights into PFGTF stock, check out TipRanks’ Stock Analysis page.
